Stock AGN ALGERNON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Algernon Pharmaceuticals Inc.

Equities

AGN

CA01559R4008

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 11:01:40 2024-05-03 am EDT 		5-day change 1st Jan Change
0.11 CAD 0.00% Intraday chart for Algernon Pharmaceuticals Inc. -15.38% +69.23%
Apr. 30 Algernon Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
Apr. 10 Algernon Pharmaceuticals Inc. announced that it has received CAD 0.017 million in funding CI

Valuation

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Capitalization 1 6.884 6.155 44.79 16.75 12.71 2.603
Enterprise Value (EV) 1 5.633 5.947 38.67 14.34 11.3 2.478
P/E ratio -7.21 x -3.06 x -3.4 x -2.01 x -1.55 x -0.37 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -6.56 x -3.37 x -4.58 x - -1.98 x -0.5 x
EV / FCF -23.2 x -6.77 x -38.4 x -3.06 x -19 x -5.06 x
FCF Yield -4.31% -14.8% -2.6% -32.7% -5.27% -19.8%
Price to Book 5.09 x 1.24 x 3.74 x 1.84 x 2.26 x 1.77 x
Nbr of stocks (in thousands) 1,147 1,894 5,429 6,699 9,432 15,776
Reference price 2 6.000 3.250 8.250 2.500 1.348 0.1650
Announcement Date 12/14/18 12/18/19 12/18/20 11/26/21 11/25/22 12/29/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -0.8582 -1.766 -8.44 - -5.708 -4.981
EBIT 1 -0.8991 -1.793 -8.467 -7.878 -5.743 -5.032
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.9376 -1.896 -8.538 -7.734 -6.054 -6.781
Net income 1 -0.9376 -1.896 -8.538 -7.734 -6.054 -6.781
Net margin - - - - - -
EPS 2 -0.8322 -1.061 -2.423 -1.241 -0.8708 -0.4477
Free Cash Flow 1 -0.2429 -0.8785 -1.007 -4.687 -0.595 -0.4897
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/14/18 12/18/19 12/18/20 11/26/21 11/25/22 12/29/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 - - - - -
EBITDA - - - - -
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income -1.836 - - - -
Net margin - - - - -
EPS -0.2750 - - - -
Dividend per Share - - - - -
Announcement Date 4/27/22 7/29/22 11/26/22 1/30/23 5/1/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.25 0.21 6.12 2.41 1.41 0.13
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.24 -0.88 -1.01 -4.69 -0.6 -0.49
ROE (net income / shareholders' equity) -63.5% -59.8% -99.3% -72.5% -82.1% -191%
ROA (Net income/ Total Assets) -36.7% -33.2% -58.3% -42.9% -39.3% -51%
Assets 1 2.552 5.717 14.65 18.03 15.41 13.3
Book Value Per Share 2 1.180 2.630 2.210 1.360 0.6000 0.0900
Cash Flow per Share 2 1.080 0.1100 1.110 0.3600 0.1500 0.0100
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 12/14/18 12/18/19 12/18/20 11/26/21 11/25/22 12/29/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ALGERNON PHARMACEUTICALS INC. Stock Algernon Pharmaceuticals Inc.
+69.23% 1.74M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.43% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+8.96% 105B
ARGENX SE Stock argenx SE
+4.40% 22.94B
BIONTECH SE Stock BioNTech SE
-12.15% 22.34B
GENMAB A/S Stock Genmab A/S
-4.36% 19.25B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.08B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.04% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.79% 14.16B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+38.61% 12.63B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. Financials Algernon Pharmaceuticals Inc.